期刊文献+

某院2016-2018年ICU多重耐药菌医院感染特点分析 被引量:11

Characteristic of Hospital-Associated Infection in ICU with Multidrug-Resistant Organisms in a hospital from 2016 to 2018
下载PDF
导出
摘要 目的:分析重症监护病区(Intensive Care Unit,ICU)多重耐药菌医院感染特点,为多重耐药菌医院感染防控提供依据。方法:对ICU多重耐药菌医院感染发生情况进行前瞻性监测,描述性分析2016-2018年ICU多重耐药菌医院感染发生情况、菌株构成以及感染部位分布,比较不同多重耐药菌菌株的医院感染部位构成、不同类型I CU分布的区别。结果:2016-2018年I CU共发生多重耐药菌医院感染197例次,医院感染发生率为2.73%、千住院日医院感染率为5.40‰;耐碳青霉烯类鲍曼不动杆菌为外科、呼吸和心外ICU最常见的多重耐药菌医院感染菌株,急诊ICU最常见的多重耐药菌医院感染菌株为耐碳青霉烯类肠杆菌科细菌;ICU多重耐药菌医院感染菌株构成:耐碳青霉烯类鲍曼不动杆菌59.39%,耐碳青霉烯类肠杆菌科细菌20.81%,耐碳青霉烯类铜绿假单胞菌16.75%,耐甲氧西林金黄色葡萄球菌3.05%;多重耐药菌的医院感染部位以呼吸系统、血流感染和切口感染为主,其中耐碳青霉烯类鲍曼不动杆菌、耐碳青霉烯类肠杆菌科细菌和耐碳青霉烯类铜绿假单胞菌的医院感染主要发生于呼吸系统,耐甲氧西林金黄色葡萄球菌医院感染部位以血流感染为主,泌尿道感染的常见多重耐药菌为耐碳青霉烯类肠杆菌科细菌。结论:ICU是多重耐药菌医院感染高发科室,应根据医院感染特点,在诊疗护理中采取针对性防控措施,尤其是对重点菌株及其重点部位医院感染的监测与防控。 Objective:To understand the characteristics of Hospital-Associated Infection(HAI)with Multidrug-Resistant Organisms(MDRO)in Intensive Care Unit(ICU),and to provide evidence for prevention and control of HAI with MDRO.Methods:Prospective surveillance of HAIs with MDRO was performed from 2016 to 2018 in ICU.Descriptive analysis the incidence,strain composition and distribution of infection sites of HAIs with MDRO in ICU,comparing the composition of hospital infection sites and the distribution of different types of ICUs in different MDRO strains.Results:There were 197 cases of HAIs with MDRO in ICU from 2016 to 2018.The incidence of HAI was 2.73%and 5.40‰/1000-hospitalization day.CRAB was the most common MDRO in surgical,respiratory and cardiac surgery ICU.The most common MDRO strain in emergency ICU was CRE.ICU MDRO strain consisted of CRAB 59.39%,CRE 20.81%,CRPA 16.75%,MRSA 3.05%.The HAIs of MDRO were mainly in respiratory system,bloodstream,and wound.The HAIs of CRAB,CRE and CRPA mainly occurred in the respiratory system.The infection of MRSA was mainly caused by bloodstream infection.CRE was common in urinary tract infections.Conclusion:ICU is a high-risk department for MDRO.According to the characteristics of HAI,targeted prevention and control measures should be taken,especially the monitoring and prevention of key strains and sites.
作者 陈美恋 王守军 匡季秋 郝云霄 高燕 CHEN Meilian;WANG Shoujun;KUANG Jiqiu;HAO Yunxiao;GAO Yan(Department of Infection Control,Peking University People's Hospital,Beijing,100044,China)
出处 《中国护理管理》 CSCD 北大核心 2019年第12期1877-1880,共4页 Chinese Nursing Management
基金 北京大学人民医院研究与发展基金(RDM 2017-01)
关键词 多重耐药菌 医院感染 重症监护病区 Multidrug-Resistant Organisms Hospital-Associated Infection Intensive Care Unit
  • 相关文献

参考文献7

二级参考文献38

  • 1Geffers C, Gastmeier P. Nosocomial infections and multidrug-resis- tant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System)[J]. Dtsch Arztebl lnt, 2011,108(6):87-93.
  • 2Lambert ML, Suetens C, Savey A, et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study [J]. Lancet Infect Dis, 2011, 11(1): 30-38.
  • 3Karah N, Sundsfjord A, Towner K, et al. Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii[J]. Drug Resist Updat, 2012, 15 (4): 237-247.
  • 4陈亮.李真,刘颖.耐亚胺培南鲍氏不动杆菌碳青霉烯酶的基因型研究[J].国际流行病学传染病学杂志,2014,41(3):168-171.
  • 5Vasudevan A, Mukhopadhyay A, Goh EY, et al. Risk factors for infection/colonization caused by resistant Gram negative bacilli in critically ill patients (an observational study of 1633 critically ill patients)[J]. Prev Med, 2013, 57 Suppl: $70-$73.
  • 6Nseir S, Blazejewski C, Lubret R, et al. Risk of acquiring mul- tidrug-resistant gram-negative bacilli from prior room occupants in the intensive care unit[J]. Clin Microbiol Infect, 2011, 17 (8): 1201-1208.
  • 7王靖,赵应兰,杨爱芝.重症监护病房控制多重耐药菌感染的体会[J].护士进修杂志,2010,25(9):860-861. 被引量:70
  • 8吴安华.提高常规手段执行力 应对超级细菌挑战[J].中国感染控制杂志,2011,10(1):1-4. 被引量:24
  • 9多重耐药菌医院感染预防与控制技术指南(试行)[J].药物不良反应杂志,2011,13(2):108-109. 被引量:128
  • 10李耘,刘健,薛峰,张秀珍,胡云建,王桂兰,褚云卓,胡志东,杨敬芳,赵旺胜,顾兵,胡必杰,俞云松,杨健,李艳,刘文恩,周玲,杨亚静,府伟灵,徐修礼,裴凤艳,杨滨,孟灵,季萍,郝凤兰,钟巍,王琪,李曼宁,齐慧敏.卫生部全国细菌耐药监测网(Mohnarin)2007-2008年报告[J].中国临床药理学杂志,2011,27(5):323-334. 被引量:77

共引文献336

同被引文献139

引证文献11

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部